These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 782220)

  • 1. Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.
    Chrysant SG; Adamopoulos P; Tsuchiya M; Frohlich ED
    Am Heart J; 1976 Sep; 92(3):335-9. PubMed ID: 782220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic mechanisms of bupicomide- and hydralazine-induced increase in plasma renin activity in hypertensive patients.
    Velasco M; McNay JL
    Mayo Clin Proc; 1977 Jul; 52(7):430-2. PubMed ID: 875465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term hemodynamic effect of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Suzuki T
    Jpn Circ J; 1976 Sep; 40(9):1025-31. PubMed ID: 994314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
    Chrysant SG; Luu TM; Danisa K; Kem DC; Manion CV
    J Cardiovasc Pharmacol; 1980; 2(2):205-14. PubMed ID: 6171687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and renal effects of enalapril and its effects on cardiac mass.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of fusaric acid and its derivative on the cardiovascular system].
    Furuta Y; Washizaki M
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):139-44. PubMed ID: 987962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate hemodynamic effects of urapidil in patients with essential hypertension.
    Kobrin I; Amodeo C; Ventura HO; Messerli FH; Frohlich ED
    Am J Cardiol; 1985 Mar; 55(6):722-5. PubMed ID: 3976516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
    Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of grip test as an index of autonomic function in hypertension.
    Chrysant SG
    Clin Cardiol; 1982 Feb; 5(2):139-43. PubMed ID: 7067186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and regional hemodynamic effects of gallopamil in patients with essential hypertension.
    Ketelhut RG; Messerli FH; Losem C; Frohlich ED; Michalewicz L
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):39-42. PubMed ID: 9140676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of converting enzyme inhibition by enalapril on renal hemodynamics in essential arterial hypertension].
    Chaignon M; Moreau L
    Presse Med; 1988 Oct; 17(34):1745-7. PubMed ID: 2855543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and regional haemodynamic effects of vasodilators in hypertension.
    Struyker-Boudier HA; Smits JF
    Neth J Med; 1984; 27(4):146-52. PubMed ID: 6330588
    [No Abstract]   [Full Text] [Related]  

  • 15. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
    Smits JF; Struyker-Boudier HA
    J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods for evaluating vasodilator agents in cardiac failure].
    Dahan M
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():63-7. PubMed ID: 2111689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
    Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
    Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methodology of hemodynamic study of a vasodilator drug (author's transl)].
    Morgant C; Merillon JP; Motte G; Guiomard A; Gourgon R
    Anesth Analg (Paris); 1980; 37(9-10):561-6. PubMed ID: 7469072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko MK; Wiesner RH; Krom RA
    Am J Hypertens; 2000 Mar; 13(3):231-9. PubMed ID: 10777026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension.
    Grossman E; Oren S; Garavaglia GE; Messerli FH; Frohlich ED
    Circulation; 1988 Dec; 78(6):1394-400. PubMed ID: 3191594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.